BDR Pharma launches generic cancer drug in India

PTIUpdated: Thursday, May 27, 2021, 02:04 PM IST
article-image
Representative image | Pixabay

Drug firm BDR Pharmaceuticals on Thursday said it has launched generic Rucaparib tablets, used to treat advanced ovarian and prostate cancers, in India.

The product is priced at a maximum retail price (MRP) of Rs 54,000 for a bottle of 60 tablets in the strength of 300 mg and at a MRP of Rs 45,000 for a bottle of 60 tablets in the strength of 200 mg, BDR Pharma said in a statement.

Rucaparib is used as a monotherapy and in conjunction with other anti-cancer agents in several tumor forms, including ovarian and prostate cancers, it added.

The company has launched its product under the brand name ''BDPARIB'', the statement said.

"BDPARIB was developed to treat patients living with advanced ovarian and prostate cancers with an unmet need... This represents a significant advancement in the treatment of cancer patients in the future," BDR Pharma CMD Dharmesh Shah said.

(To receive our E-paper on whatsapp daily, please click here. To receive it on Telegram, please click here. We permit sharing of the paper's PDF on WhatsApp and other social media platforms.)

RECENT STORIES

Mumbai Metropolitan Region records highest sales of approx 25,785 units in Q2 2022

Mumbai Metropolitan Region records highest sales of approx 25,785 units in Q2 2022

Uddhav Thackeray has lost fighting spirit: Former CM Prithviraj Chavan

Uddhav Thackeray has lost fighting spirit: Former CM Prithviraj Chavan

Daily Horoscope for Friday, July 1, 2022, for all zodiac signs by astrologer Vinayak Vishwas...

Daily Horoscope for Friday, July 1, 2022, for all zodiac signs by astrologer Vinayak Vishwas...

Mumbai cruise drugs case: Aryan Khan seeks passport back as exonerated in drugs case

Mumbai cruise drugs case: Aryan Khan seeks passport back as exonerated in drugs case

Navi Mumbai: NMMC area sees 190 new cases of Covid-19 on June 29

Navi Mumbai: NMMC area sees 190 new cases of Covid-19 on June 29